Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro

Clinical and Experimental Allergy

Volumn 26, Issue 10, 1996, Pages 1188-1196

  Buscaglia, S ^a,b   Paolieri, F ^a   Catrullo, A ^a   Fiorino, N ^a   Riccio, A M ^a   Pesce, G ^a   Montagna, P ^a   Bagnasco, M ^a   Ciprandi, G ^a   Canonica, G W ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Allerg and Clin Immunology Service   (Italy)

Author keywords

Adhesion molecules; Allergen specific conjunctival challenge; Allergic conjunctivitis; Allergic inflammation; Anti allergic drugs; ICAM 1; Levocabastine; sICAM 1

Indexed keywords

EYE DROPS; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; LEVOCABASTINE; PLACEBO;

ADULT; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EPITHELIUM CELL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ACUTE-PHASE REACTION; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; CELLS, CULTURED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION ROUTES; EPITHELIUM; EYE; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; PIPERIDINES;

EID: 10244252766     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00507.x     Document Type: Article

References (33)

1. Friedlander MH. Ocular allergy. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Younginger JW, Busse, WW, eds. Allergy: principles and practice. St Louis: Mosby, 1993; 1649-60.
2. Abelson MB, Schaefer K. Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Sur Ophthalmol 1993; 38 (suppl):115-32.
3. Brown PH, Crompton GK, Greening AP. Proinflammatory cytokines in acute asthma. Lancet 1991; 338:590-3.
4. Shute J. Interleukine-8 is a potent eosinophil chemoattractant. Clin Exp Allergy 1994; 24:203-6.
5. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 1994; 94 (3):427-38.
6. Schwartz L, Huff T. Biology of mastcells and basophils. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Younginger JW, Busse WW, eds. Allergy: principles and practice. St Louis: Mosby, 1993: 135-66.
7. Baddaley SM, Bacon AS, McGill JI, Lightman SL, Holgate ST, Roche WR. Mast cell distribution and neutral protease expression in acute and chronic allergic conjunctivitis. Clin Exp Allergy 1995; 25:41-50.
8. Canonica GW, Ciprandi G, Buscaglia S, Pesce G, Bagnasco M. Adhesion molecules of allergic inflammation: recent insights into their functional roles. Allergy 1994; 49:135-41.
9. Makgoba MW, Sanders ME, Luce GEG et al. ICAM-1 a ligand for LFA-1 dependent adhesion of B, T and myeloid cells. Nature 1988; 331:86-91.
10. Staunton DE, Marlin SD Stratowa C, Dustin ML, Springer TA. Primary structure of intercellular adhesion molecule-1 (ICAM-1) demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988; 52:925-33.
11. Altman LC, Ayars GH, Baker C, Luchtel DL. Cytokines and eosinophil-derived cationic proteins upregulate intercellular adhesion molecule-1 on human nasal epithelial cells. J Allergy Clin Immunol 1993; 92:527-36.
12. Montefort S, Roche WR, Howarth PH et al. Intercellular adhesion molecule-1 (ICAM-1) and endothelial leukocyte adhesion molecule (ELAM-1) expression in the bronchial mucosa of normal and asthmatic subjects. Eur Respir J 1992; 5:815-23.
13. Pesce GP, Fiorino N, Buscaglia S, Ciprandi G, Riccio AM, Bagnasco M, Canonica GW. In situ hybridization analysis of ICAM-1 (CD54) expression on conjunctival epithelium during allergic inflammation. ACI News 1994; Suppl 2:13.
14. Raeburn D, Webber SE. Proinflammatory potential of the epithelium in bronchial asthma. Eur Respir J 1994; 7:2226-33.
15. Dechant KL, Goa KL. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs 1991; 41(2):202-24.
16. Stokes TC, Feinberg G. Rapid onset of action of levocabastine eye drops in histamine-induced conjunctivitis. Clin Exp Allergy 1993; 23:791-4.
17. 1 antagonist in patients with allergic conjunctivitis. Allergy 1985; 40:491-6.
18. 1 antagonist, in seasonal allergic rhinoconjunctivitis. Allergy 1987; 42:512-5.
19. Bahmer FA. Topical levocabastine an effective alternative to oral antihistamines in seasonal allergic rhinoconjunctivitis. Clin Exp Allergy 1995; 25:220-7.
20. Ciprandi G, Buscaglia S, Pesce GP, Villaggio B, Bagnasco M, Canonica GW. Allergic subjects express intercellular adhesion molecule-1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge. J Allergy Clin Immunol 1993; 91:783-92.
21. Ciprandi G, Buscaglia S, Pesce GP, Iudice A, Bagnasco M, Canonica GW. Deflazacort protects late phase but not early phase events induced by allergen specific conjunctival provocation test. Allergy 1993; 48:421-30.
22. 1-receptor-antagonist drugs. New Engl J Med 1994; 330 (23):1663-70.
23. Kempt JP. Antihistamines is there anything safe to prescribe? Ann Allergy 1992; 69:276-280.
24. 1 antagonist, in a conjunctival provocation test with allergens. J Allergy Clin Immunol 1988; 82:590-4.
25. Ciprandi G, Buscaglia S, Pesce GP et al. Cetirizine reduces inflammatory cell recruitment and ICAM-1 CD54 expression on conjunctival epithelium both in early and late phase events following allergen specific challenge. J Allergy Clin Immunol 1994 95:612-21.
26. Ciprandi G, Buscaglia S, Pronzato C, Benvenuti C, Cavalli E, Bruzzone F, Canonica GW. Oxatomide reduces inflammatory events induced by allergen-specific conjunctival challenge. Ann Allergy 1995; 75:446-52.
27. Barnes PJ. Future drug therapy for asthma. Clin Exp Allergy 1991; 21 (suppl 1):80-5.
28. Abelson MB, Smith LM. Evaluation in the histamine and compound 48.80 models of ocular allergy in humans. Ophtalmol 1988; 95:1494-7.
29. Pecoud A, Zuber P, Kolly M. Effect of a new selective H1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test. Int Arch Allergy Appl Immunol 1987; 82:541-3.
30. Howarth PH, Fell P, Selvam A. Levocabastine in allergic conjunctivitis. Clin Exp Allergy 1994; 24:184-88.
31. Ciprandi G, Buscaglia S, Pesce GP, Bagnasco M, Canonica GW. Ocular challenge and hyperresponsiveness to histamine in patients with allergic conjunctivitis. J Allergy Clin Immunol 1993; 91:1227-30.
32. Abelson MB, George MA, Garofalo C. Differential diagnosis of ocular allergic disorders. Ann Allergy 1993; 70:95-109.
33. 1-receptor antagonist, on nasal provocation reaction to allergen. Am J Rhinology 1995 (in press).